Transabdominal Gastric Contrast Ultrasound
Application Value of Transabdominal Gastric Contrast Ultrasound in the Diagnosis and Staging Evaluation of Gastric Cancer
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Wei Li, Prof.
- Phone Number: 13596157865
- Email: weili8308@126.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age: 18~80 years old, male or female;
- Diagnosed with gastric cancer by histology or cytology;
- No distant multiple metastasis;
- ECOG score 0-2;
- Heart, lung, liver and kidney function can tolerate surgery;
- Patients and their families can understand and be willing to participate in this clinical study, and sign the informed consent.
Exclusion Criteria:
- Previous history of malignant tumor or recent diagnosis combined with other malignant tumors;
- Patients with gastrointestinal perforation, gastrointestinal bleeding, etc. requiring emergency surgery;
- Patients with previous gastroduodenal surgery;
- Preoperative neoadjuvant therapy;
- Patients and their families refuse surgical treatment;
- ASA grade ≥ IV and/or ECOG performance status score > 2;
- Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases who cannot tolerate surgery;
- Have a history of serious mental illness;
- Pregnant or lactating women;
- Patients with other clinical and laboratory conditions considered by the researchers should not participate in this trial.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental group
Patients with gastric cancer underwent contrast-enhanced CT scan and gastric filling ultrasound, respectively.
|
Gastric contrast ultrasound (GCUS) refers to that the patient fills the stomach cavity with oral water, contrast agent and ultrasound contrast agent before the examination to remove the gas in the stomach cavity and fill the stomach cavity to become a homogeneous echo area and form a good acoustic sound. Interface contrast, more clearly showing the gastric wall hierarchy and the ultrasound examination method of the lesions. In this way, not only the changes of the gastrointestinal mucosa can be found, but also the submucosal tumors of the gastrointestinal tract can be clearly displayed, the internal structural characteristics of the tumor, the extent of the lesions, the depth of infiltration, the TNM staging of the tumor, and the lesions of the surrounding organs can be displayed. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sensitivity, specificity and accuracy of gastric contrast ultrasound in judging gastric cancer staging.
Time Frame: one month after surgery
|
one month after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Wei Li, Prof., The First Hospital of Jilin University
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- CUS-GC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.